Novartis related Press Releases
PaxVax Expands Executive Management Team
Accomplished Vaccine Industry Executives Appointed to COO, CTO and CSO Positions MENLO PARK, Calif.--(BUSINESS WIRE)-- PaxVax Corporation, developer of innovative and socially responsible oral Read more...
AMAG Pharmaceuticals Announces the Appointment of Two Independent Directors to its Board
~Evaluation of Strategic Alternatives Ongoing~ LEXINGTON, Mass.--(BUSINESS WIRE)-- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of Rajiv De Silva and Gino Santini to its Read more...
GenVec Extends Research Collaboration with Global Pharmaceutical Company
GAITHERSBURG, Md., Jan. 27, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC), a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines, Read more...
Kedem Pharmaceuticals Initiates Development of Sublingual Anti-Cancer Drug, Gleevec®
Kedem Pharmaceuticals Initiates Development of Sublingual Anti-Cancer Drug, Gleevec® PHOENIX,, Jan. 12, 2012 /PRNewswire/ -- Kedem Pharmaceuticals Inc. (OTCBB: KDMP), a specialty pharmaceutical Read more...
AnaptysBio Announces New Strategic Antibody Discovery
Alliances With Two Pharma PartnersSAN DIEGO, Jan. 6, 2012 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the initiation of new strategic alliances Read more...
Forma Expands Drug Discovery Team with Three Executive Appointments
WATERTOWN, Mass.--(BUSINESS WIRE)-- FORMA Therapeutics today announced three new additions to its R&D team, greatly expanding its oncology drug discovery capabilities. Jaime Escobedo, Ph.D., has Read more...
BASF, GlaxoSmithKline, Merck and Novartis Among Companies to Schedule Partnering Sessions at CED Life Science Conference 2
Early registration encouraged to secure limited opportunities DURHAM, N.C.--(BUSINESS WIRE)-- CED, the Southeast’s largest entrepreneurial support organization, today opened registration for Read more...
First U.S. cell-based flu vaccine plant set for dedication
Facility’s ability to produce cell-based pandemic flu vaccine marks historic change WASHINGTON--(BUSINESS WIRE)-- The first U.S. facility to use a faster and more flexible technology to make Read more...
GenVec Achieves Second Milestone in Collaboration
GAITHERSBURG, Md., Dec. 6, 2011 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) today announced that it has achieved the second milestone in its collaboration with Novartis (NYSE: NVS), related to the Read more...
Novartis gains European Commission approval for Rasitrio®, a Rasilez-based triple combination pill to treat high blood pressure
Novartis gains European Commission approval for Rasitrio®, a Rasilez-based triple combination pill to treat high blood pressure Pivotal phase III data showed significantly greater blood pressure Read more...
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
